Since BCSCs were first identified in 2003 based on CD44 and CD24 expression [38], different biomarkers for BCSCs have been identified in BC patient tumor samples, animal models, and cell lines, indicating the existence of a variety of BCSC subgroups. This evidence concerns the gene CD44 and breast cancer.